kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant HIV-1 (CN54) GP120 Protein, His Tag, 100 µg  

Recombinant HIV-1 (CN54) GP120 Protein, His Tag, 100 µg

Recombinant HIV-1 GP120 Protein (HIV-1 /Clade B/C (CN54)) derived from the env. gene of HIV-1 strain CN54 gp160, Thr 36 - Arg 507, glycosylated with N-linked sugars and expressed in HEK293 cells, His Tag

Synonym: recombinant, human protein, GP120,GP120-CN54

More details


338,00 €

Human Immunodeficiency Virus (HIV) can be divided into two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa. HIV-2 is related to viruses found in sooty mangabeys. HIV-1 viruses may be further divided into groups. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Some of the HIV-1 group M subtypes are known to be more virulent or are resistant to different medications. HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses. Envelope glycoprotein GP120 (or gp120) is the name of the glycoprotein which forms the spikes sticking out of a HIV virus particle. gp120 is essential for virus entry into cells as it plays a vital role in seeking out specific cell surface receptors for entry. Three gp120s, bound as heterodimers to a transmembrane glycoprotein, gp41, are thought to combine in a trimer to form the envelope spike, which is involved in virus-cell attachment. One half of the molecular weight of gp120 is due to the carbohydrate side chains (the "glyco-" in "glycoprotein"). These are sugar residues which form something almost like a sugar "dome" over the gp120 spikes. This dome prevents gp120 from being recognised by the human immune response. As the HIV virus and the human CD4 cell come together, the gp120 binding site "snaps open" at the last minute.The glycoprotein gp120 is anchored to the viral membrane, or envelope, via non-covalent bonds with the transmembrane glycoprotein, gp41. It is involved in entry into cells by binding to CD4 receptors, particularly helper T-cells. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds.

Recombinant HIV-1 [HIV-1/Clade B/C (CN54)] GP120, His Tag derived from the env. gene of HIV-1 strain CN54 gp160 (Accession # G4XFJ5-1(E46G, T396A, A497T), Thr 36 - Arg 507) and glycosylated with N-linked sugars and expressed in HEK293 cells at ACRObiosystems.
Predicted N-terminus: Thr 36

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 53.8 kDa. The protein migrates as 85-150 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 1.0 EU per μg by the LAL method.
>95% as determined by SDS-PAGE.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Please refer to product data sheet.

Clinical and Translational Updates

(1) "Kynurenic acid blunts A1 astrocyte activation against neurodegeneration in HIV-associated neurocognitive disorders"
Lun, Li, Gao et al
J Neuroinflammation (2023) 20 (1), 87
(2) "Piperidine CD4-mimetic compounds expose vulnerable Env epitopes sensitizing HIV-1-infected cells to ADCC"
Ding, Tolbert, Zhu et al
bioRxiv (2023)
(3) "Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIVmac251 Acquisition"
Stamos, Rahman, Gorini et al
J Virol (2023)
Showing 1-3 of 10991 papers.


IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine
Authors: S Sarkar, et al
Journal: Vaccine 2019
Application: ELISA

Enabling electrical biomolecular detection in high ionic concentrations and enhancement of the detection limit thereof by coupling a nanofluidic crystal with reconfigurable ion concentration polarization
Authors: Ouyang W, et al.
Journal: Lab Chip 2017
Application: BLI